Bombesin (BBN), a 14 amino acid peptide, and its analogues based on this 14-amino acid backbone sequence (e.g., BBN 6–14) have been investigated as targeting ligands for diagnosis and therapy of GRPR-positive tumours using several different radionuclides [61,62]. The gene discussed is GRP; the disease is neoplasm.